UnitedHealth Group (NYSE:UNH) was downgraded by equities researchers at ValuEngine from a “buy” rating to a “hold” rating in a report issued on Thursday.
A number of other equities analysts also recently weighed in on UNH. Cowen reissued an “outperform” rating and set a $220.00 target price (up previously from $175.00) on shares of UnitedHealth Group in a research note on Friday, August 11th. Morgan Stanley raised their price target on shares of UnitedHealth Group from $210.00 to $215.00 and gave the stock an “overweight” rating in a report on Thursday, August 17th. Jefferies Group restated a “buy” rating and issued a $215.00 price target on shares of UnitedHealth Group in a report on Friday, August 18th. UBS restated an “overweight” rating on shares of UnitedHealth Group in a report on Thursday, August 24th. Finally, Cantor Fitzgerald restated a “buy” rating on shares of UnitedHealth Group in a report on Tuesday, August 29th. Three analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $224.56.
Shares of UnitedHealth Group (UNH) traded up $0.21 during midday trading on Thursday, reaching $220.15. 2,661,839 shares of the company were exchanged, compared to its average volume of 3,114,195. UnitedHealth Group has a fifty-two week low of $156.09 and a fifty-two week high of $231.77. The company has a market capitalization of $213,282.06, a P/E ratio of 22.93, a PEG ratio of 1.63 and a beta of 0.66. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The business had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. During the same quarter last year, the firm earned $2.17 earnings per share. UnitedHealth Group’s quarterly revenue was up 8.7% on a year-over-year basis. analysts anticipate that UnitedHealth Group will post 9.99 earnings per share for the current year.
In related news, Director Michele J. Hooper sold 5,000 shares of the firm’s stock in a transaction dated Monday, December 4th. The shares were sold at an average price of $222.20, for a total transaction of $1,111,000.00. Following the transaction, the director now directly owns 36,989 shares of the company’s stock, valued at $8,218,955.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Larry C. Renfro sold 50,574 shares of the firm’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the transaction, the insider now directly owns 195,625 shares in the company, valued at $38,755,268.75. The disclosure for this sale can be found here. Insiders have sold 62,606 shares of company stock worth $12,677,525 over the last three months. 0.89% of the stock is owned by insiders.
Several institutional investors and hedge funds have recently added to or reduced their stakes in UNH. Institutional & Family Asset Management LLC raised its position in UnitedHealth Group by 4.6% in the third quarter. Institutional & Family Asset Management LLC now owns 19,346 shares of the healthcare conglomerate’s stock worth $3,789,000 after acquiring an additional 857 shares during the period. Steward Partners Investment Advisory LLC bought a new stake in shares of UnitedHealth Group in the third quarter valued at approximately $7,787,000. Visionary Asset Management Inc. bought a new stake in shares of UnitedHealth Group in the third quarter valued at approximately $309,000. Jana Partners LLC bought a new stake in shares of UnitedHealth Group in the third quarter valued at approximately $44,601,000. Finally, Public Employees Retirement System of Ohio raised its position in shares of UnitedHealth Group by 1.2% in the third quarter. Public Employees Retirement System of Ohio now owns 711,891 shares of the healthcare conglomerate’s stock valued at $139,424,000 after purchasing an additional 8,769 shares during the period. 86.20% of the stock is currently owned by institutional investors.
ILLEGAL ACTIVITY WARNING: This article was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another publication, it was illegally stolen and republished in violation of US & international copyright & trademark legislation. The original version of this article can be viewed at https://www.dispatchtribunal.com/2017/12/08/unitedhealth-group-unh-stock-rating-lowered-by-valuengine.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.